MME (Morphine Milligram Equivalent) Calculator
Calculate morphine milligram equivalents (MME) for opioid conversion using CDC factors. Select opioid type and dose for MME value, risk category, and conversion charts.
About This Calculator
The MME (Morphine Milligram Equivalent) Calculator converts doses of various opioid medications into a standardized morphine equivalent using CDC-recommended conversion factors. This tool helps healthcare professionals assess total opioid burden, identify patients at elevated risk of overdose, and make informed prescribing decisions. It supports the most commonly prescribed opioids including morphine, codeine, oxycodone, hydrocodone, hydromorphone, fentanyl transdermal patches, methadone (with dose-dependent conversion), oxymorphone, tapentadol, and tramadol.
Each opioid has a specific conversion factor reflecting its potency relative to oral morphine. For example, oxycodone has a factor of 1.5 (1.5 times more potent than morphine), while tramadol has a factor of 0.1 (one-tenth as potent). Methadone has unique dose-dependent conversion due to its complex pharmacology, with higher conversion factors at higher daily doses. The calculator applies the appropriate factor and displays the total daily MME, the conversion factor used, and the corresponding CDC risk category.
CDC MME Thresholds
The CDC Clinical Practice Guideline for Prescribing Opioids for Pain identifies two key thresholds: < 50 MME/day — lower risk of overdose; 50–89 MME/day — moderate risk, at least 2 times increased overdose risk; and ≥ 90 MME/day — high risk, 4 to 9 times increased overdose risk. These thresholds guide clinical decision-making about opioid tapering, enhanced monitoring, and naloxone co-prescribing.
Regional Notes
Global: MME calculations are recommended by the World Health Organization (WHO) for monitoring opioid use and assessing overdose risk. Conversion factors may vary by country — always verify against local clinical guidelines and formularies.
US: The CDC conversion factors are the standard for clinical practice, prescription drug monitoring programs (PDMPs), and electronic health record MME calculations. Many US states have laws requiring MME monitoring and limiting high-dose opioid prescriptions.
UK: The British National Formulary (BNF) provides morphine equivalence factors that differ slightly from CDC values. UK clinicians should use the BNF-recommended factors for clinical decision-making.
India: The Narcotics Control Bureau and ICMR guidelines regulate opioid prescribing. MME awareness is growing as part of opioid stewardship programs in Indian hospitals. Use this calculator for reference and educational purposes, and verify against local guidelines.
This calculator is for educational and clinical reference purposes only. Always consult a healthcare professional for medical decisions regarding opioid prescribing and pain management.
Frequently Asked Questions
What is a morphine milligram equivalent (MME)?
A morphine milligram equivalent (MME) is a standard unit that converts the dose of different opioids into an equivalent dose of oral morphine. This allows clinicians to compare the potency of various opioid medications on a common scale. For example, 1 mg of morphine equals 1 MME, while 1 mg of oxycodone equals 1.5 MME because oxycodone is 1.5 times more potent than morphine. MME calculations are essential for assessing total opioid burden, monitoring for high-risk prescribing, and reducing the risk of opioid overdose.
How is MME calculated for different opioids?
MME is calculated by multiplying the prescribed opioid dose by the CDC-recommended conversion factor for that specific opioid. For oral opioids: morphine (factor 1), codeine (0.15), oxycodone (1.5), hydrocodone (1), hydromorphone (4), oxymorphone (3), tramadol (0.1), and tapentadol (0.4). For fentanyl transdermal patches, the MME conversion factor is 2.4 per mcg per hour. Methadone has variable conversion factors based on total daily dose: 1-20 mg/day (factor 4), 21-40 mg/day (factor 8), 41-60 mg/day (factor 10), and over 60 mg/day (factor 12). The total daily MME is the sum of all opioid doses converted to MME.
What are the CDC MME threshold recommendations?
The CDC Clinical Practice Guideline for Prescribing Opioids identifies two key MME thresholds for overdose risk. A total daily MME of 50 or more increases the risk of opioid overdose by at least 2 times compared to lower doses. A total daily MME of 90 or more increases the overdose risk by 4 to 9 times. The CDC recommends careful justification and enhanced monitoring when prescribing opioids at or above 50 MME per day, and generally advises avoiding doses at or above 90 MME per day. These thresholds apply to adults with chronic pain and are not intended for acute pain management, cancer pain, or end-of-life care.
Why is MME conversion important in clinical practice?
MME conversion is important because it allows healthcare providers to assess a patient's total opioid exposure when they are prescribed multiple different opioids or when transitioning between opioid medications. It helps identify patients at high risk of overdose, supports safe opioid prescribing decisions, and enables compliance with regulatory requirements for monitoring high-dose opioid therapy. Many electronic health records and prescription drug monitoring programs (PDMPs) automatically calculate MME to flag potentially dangerous prescribing patterns. MME calculations are also used in clinical guidelines from the CDC, WHO, and national health agencies worldwide.
What is the difference between MME and morphine equivalence?
MME (morphine milligram equivalent) and morphine equivalence generally refer to the same concept — converting opioid doses to an oral morphine equivalent. However, the term MME is specifically used by the CDC and in US clinical guidelines, while other terms like oral morphine equivalent (OME) or morphine equivalent daily dose (MEDD) are used internationally. The conversion factors may vary slightly between different guidelines. For example, the CDC-published conversion factors used in this calculator are widely adopted in the United States, while the UK and other countries may use factors from the British National Formulary (BNF) or other national formularies.
Can MME be calculated for all opioid formulations?
MME conversion factors are available for most commonly prescribed opioid formulations including oral immediate-release, oral extended-release, and transdermal formulations. However, conversion factors are not available for all routes of administration or all opioid medications. For example, intravenous and epidural opioid conversions are more complex and require specialized clinical expertise. Additionally, MME conversion tables may not accurately account for incomplete cross-tolerance between different opioids, genetic variations in opioid metabolism, or organ dysfunction that affects drug clearance. MME calculations are estimates and should always be interpreted in the context of the individual patient's clinical condition.
How should MME results be used in patient care?
MME results should be used as a screening and monitoring tool, not as the sole determinant of clinical decisions. When total daily MME exceeds 50, clinicians should carefully evaluate the benefits and risks of continued opioid therapy, consider non-opioid alternatives, and implement enhanced monitoring including regular follow-up, urine drug testing, and review of PDMP data. When MME exceeds 90, clinicians should consider tapering or discontinuing opioids where possible, and if continuing, ensure robust risk mitigation strategies including naloxone co-prescribing. MME calculations should be combined with clinical judgment, patient preferences, and a comprehensive pain management plan.
Are MME conversion factors the same worldwide?
MME conversion factors vary slightly between different countries and clinical guidelines. The United States uses CDC-recommended conversion factors which are the standard for clinical practice and prescription drug monitoring programs. The United Kingdom and many European countries rely on the British National Formulary (BNF) or national opioid conversion guidelines which may differ in specific conversion ratios. For example, the UK conversion factor for codeine is often listed as 0.1 rather than the US factor of 0.15. In India, opioid prescribing guidelines from the Indian Council of Medical Research (ICMR) and the Narcotics Control Bureau generally follow WHO recommendations. Clinicians should use the conversion factors appropriate for their practice setting and regulatory environment.